Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genentech exec, three Caremark execs acquitted in Medicare/Medicaid Protropin kickback trial.

Executive Summary

GENENTECH EXEC, THREE CAREMARK EMPLOYEES ACQUITTED of all charges in the Medicare/Medicaid anti-remuneration trial by Minneapolis federal court Judge David Doty Oct. 3. Genentech VP-Sales & Marketing Edmon Jennings and Caremark VPs James Mieszala and Joseph Herring and General Manager Judy Giel were cleared of the Minnesota U.S. Attorney's August 1994 charges that they had provided kickbacks to physicians in exchange for prescribing Genentech's Protropin human growth hormone ("The Pink Sheet" Aug. 8, 1994, p. 3).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026980

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel